University of Bath’s ‘Research with Impact’ Series Showcases EnsiliTech’s Mission to Revolutionise Global Vaccine Access
Bristol, 20 October 2025 – EnsiliTech®, a University of Bath spin-out pioneering heat-stable vaccine and biologics technology, has been spotlighted by the University’s Research with Impact platform in a new feature, “Science Meets Policy: How Bath research in chemistry and biology is helping to prepare for global heath emergencies.” The article explores how world-leading research from EnsiliTech is strengthening pandemic preparedness and improving access to life-saving vaccines.
📖 Read the full feature: Science Meets Policy – Research with Impact, University of Bath
The piece highlights how EnsiliTech’s breakthrough Ensilication® technology - which removes the need for cold storage by encasing biological materials in a protective silica shell - has the potential to transform how vaccines are stored and distributed worldwide. By keeping vaccines stable at ambient temperatures, EnsiliTech aims to expand access in regions lacking refrigeration infrastructure, whilst also reducing emissions and cutting wastage.
“We’re proud that our work is featured as an example of how academic research and policy engagement can come together to drive real-world change,” said Dr Asel Sartbaeva, CEO of EnsiliTech. “By bridging the gap between the lab bench and government decision-making, we can help ensure innovations like ours have the greatest possible global impact.”
The Research with Impact article situates EnsiliTech’s work within a broader context of how scientists are collaborating with policymakers to ensure that cutting-edge science has a direct impact on UK preparedness. For EnsiliTech, this underscores the company’s growing reputation as a scientific innovator.
As global health systems continue to prepare for future outbreaks, EnsiliTech’s technology is being positioned not only as a technical breakthrough but as a strategic enabler of equitable vaccine delivery - ensuring life-saving treatments can reach communities everywhere, regardless of infrastructure.
About EnsiliTech
Ensilicated Technologies Ltd is a pioneering biotechnology company dedicated to enhancing the stability and accessibility of biopharmaceuticals through its proprietary Ensilication technology. EnsiliTech is a Bristol-based startup, which spun out from the University of Bath in 2022. Our mission is to democratise access to therapeutics and biologicals by making them room-temperature stable; improving logistics whilst reducing overall environmental impact.
For more information about EnsiliTech please visit www.ensilitech.com or connect on LinkedIn.